GlassScriptPhysician profile
Kenton K Murthy
NPI 1891042339
$40,453.80
in general payments reported to CMS, 2019-2025
8 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $116 · 2021: $229 · 2022: $14.92 · 2023: $138 · 2024: $17K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $4,344 · Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,025.00 |
| Travel and Lodging | $4,344.46 |
| Food and Beverage | $1,425.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $39,700.00 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $307.84 | 2019-2025 | Dovato, Cabenuva |
| Janssen Products, LP | $169.94 | 2019-2021 | |
| Janssen Biotech, INC. | $118.12 | 2019-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $101.44 | 2019-2024 | Delstrigo, Pifeltro, Dificid |
| Glaxosmithkline, LLC. | $26.10 | 2023 | Arexvy |
| Genentech USA, INC. | $16.11 | 2020 | |
| Hologic Sales and Service, LLC | $14.25 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenton Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.